Medincell (France) Market Value

MEDCL Stock  EUR 17.42  0.26  1.52%   
Medincell's market value is the price at which a share of Medincell trades on a public exchange. It measures the collective expectations of Medincell SA investors about its performance. Medincell is selling at 17.42 as of the 24th of November 2024; that is 1.52% up since the beginning of the trading day. The stock's last reported lowest price was 16.94.
With this module, you can estimate the performance of a buy and hold strategy of Medincell SA and determine expected loss or profit from investing in Medincell over a given investment horizon. Check out Medincell Correlation, Medincell Volatility and Medincell Alpha and Beta module to complement your research on Medincell.
Symbol

Please note, there is a significant difference between Medincell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medincell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medincell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Medincell 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medincell's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medincell.
0.00
10/25/2024
No Change 0.00  0.0 
In 31 days
11/24/2024
0.00
If you would invest  0.00  in Medincell on October 25, 2024 and sell it all today you would earn a total of 0.00 from holding Medincell SA or generate 0.0% return on investment in Medincell over 30 days. Medincell is related to or competes with Biophytis, Gensight Biologics, OSE Pharma, and Abivax SA. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers an... More

Medincell Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medincell's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medincell SA upside and downside potential and time the market with a certain degree of confidence.

Medincell Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Medincell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medincell's standard deviation. In reality, there are many statistical measures that can use Medincell historical prices to predict the future Medincell's volatility.
Hype
Prediction
LowEstimatedHigh
15.0817.4219.76
Details
Intrinsic
Valuation
LowRealHigh
14.7017.0419.38
Details
Naive
Forecast
LowNextHigh
14.2516.5918.92
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
17.0917.3317.58
Details

Medincell SA Backtested Returns

Medincell SA has Sharpe Ratio of -0.0105, which conveys that the firm had a -0.0105% return per unit of risk over the last 3 months. Medincell exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medincell's Standard Deviation of 2.34, insignificant risk adjusted performance, and Mean Deviation of 1.65 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.94, which conveys possible diversification benefits within a given portfolio. Medincell returns are very sensitive to returns on the market. As the market goes up or down, Medincell is expected to follow. At this point, Medincell SA has a negative expected return of -0.0244%. Please make sure to verify Medincell's potential upside, and the relationship between the total risk alpha and daily balance of power , to decide if Medincell SA performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.22  

Weak reverse predictability

Medincell SA has weak reverse predictability. Overlapping area represents the amount of predictability between Medincell time series from 25th of October 2024 to 9th of November 2024 and 9th of November 2024 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medincell SA price movement. The serial correlation of -0.22 indicates that over 22.0% of current Medincell price fluctuation can be explain by its past prices.
Correlation Coefficient-0.22
Spearman Rank Test-0.75
Residual Average0.0
Price Variance0.21

Medincell SA lagged returns against current returns

Autocorrelation, which is Medincell stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medincell's stock expected returns. We can calculate the autocorrelation of Medincell returns to help us make a trade decision. For example, suppose you find that Medincell has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Medincell regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medincell stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medincell stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medincell stock over time.
   Current vs Lagged Prices   
       Timeline  

Medincell Lagged Returns

When evaluating Medincell's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medincell stock have on its future price. Medincell autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medincell autocorrelation shows the relationship between Medincell stock current value and its past values and can show if there is a momentum factor associated with investing in Medincell SA.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Medincell Stock Analysis

When running Medincell's price analysis, check to measure Medincell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medincell is operating at the current time. Most of Medincell's value examination focuses on studying past and present price action to predict the probability of Medincell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medincell's price. Additionally, you may evaluate how the addition of Medincell to your portfolios can decrease your overall portfolio volatility.